Follow
Lorinc Sandor Pongor
Lorinc Sandor Pongor
HCEMM
Verified email at hcemm.eu - Homepage
Title
Cited by
Cited by
Year
MGMT status as a clinical biomarker in glioblastoma
M Butler, L Pongor, YT Su, L Xi, M Raffeld, M Quezado, J Trepel, K Aldape, ...
Trends in cancer 6 (5), 380-391, 2020
1642020
TPMCalculator: one-step software to quantify mRNA abundance of genomic features
R Vera Alvarez, LS Pongor, L Marińo-Ramírez, D Landsman
Bioinformatics 35 (11), 1960-1962, 2019
1462019
A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients
L Pongor, M Kormos, C Hatzis, L Pusztai, A Szabó, B Győrffy
Genome medicine 7, 1-11, 2015
1222015
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
DK Patten, G Corleone, B Győrffy, Y Perone, N Slaven, I Barozzi, E Erdős, ...
Nature Medicine 24 (9), 1469-1480, 2018
1202018
SCLC-CellMiner: a resource for small cell lung cancer cell line genomics and pharmacology based on genomic signatures
C Tlemsani, L Pongor, F Elloumi, L Girard, KE Huffman, N Roper, ...
Cell reports 33 (3), 2020
962020
Wanted DEAD/H or alive: helicases winding up in cancers
W Cai, Z Xiong Chen, G Rane, S Satendra Singh, Z Choo, C Wang, ...
JNCI: Journal of the National Cancer Institute 109 (6), djw278, 2017
942017
Predictors of chemosensitivity in triple negative breast cancer: an integrated genomic analysis
T Jiang, W Shi, VB Wali, LS Pongor, C Li, R Lau, B Győrffy, RP Lifton, ...
PLoS medicine 13 (12), e1002193, 2016
912016
TP53 mutation hits energy metabolism and increases glycolysis in breast cancer
H Harami-Papp, LS Pongor, G Munkácsy, G Horváth, ÁM Nagy, A Ambrus, ...
Oncotarget 7 (41), 67183, 2016
562016
Chromatin remodeling and immediate early gene activation by SLFN11 in response to replication stress
J Murai, H Zhang, L Pongor, SW Tang, U Jo, F Moribe, Y Ma, M Tomita, ...
Cell reports 30 (12), 4137-4151. e6, 2020
532020
A small protein encoded by a putative lncRNA regulates apoptosis and tumorigenicity in human colorectal cancer cells
XL Li, L Pongor, W Tang, S Das, BR Muys, MF Jones, SB Lazar, ...
Elife 9, e53734, 2020
522020
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies
C Tlemsani, N Takahashi, L Pongor, VN Rajapakse, M Tyagi, X Wen, ...
Science translational medicine 13 (578), eabc7488, 2021
442021
KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
Á Nagy, LS Pongor, A Szabó, M Santarpia, B Győrffy
International journal of cancer 140 (4), 930-937, 2017
412017
BAMscale: quantification of next-generation sequencing peaks and generation of scaled coverage tracks
LS Pongor, JM Gross, R Vera Alvarez, J Murai, SM Jang, H Zhang, ...
Epigenetics & chromatin 13, 1-13, 2020
392020
Mutations defining patient cohorts with elevated PD-L1 expression in gastric cancer
O Menyhárt, LS Pongor, B Győrffy
Frontiers in Pharmacology 9, 430580, 2019
332019
The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma
BR Muys, DG Anastasakis, D Claypool, L Pongor, XL Li, I Grammatikakis, ...
Genes & Development 35 (1-2), 102-116, 2021
322021
DNA and RNA cleavage complexes and repair pathway for TOP3B RNA-and DNA-protein crosslinks
S Saha, Y Sun, SN Huang, SA Baechler, LS Pongor, K Agama, U Jo, ...
Cell reports 33 (13), 2020
282020
Dynamics of replication origin over-activation
H Fu, CE Redon, BL Thakur, K Utani, R Sebastian, SM Jang, JM Gross, ...
Nature Communications 12 (1), 3448, 2021
272021
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes
B Győrffy, L Pongor, G Bottai, X Li, J Budczies, A Szabó, C Hatzis, ...
British Journal of Cancer 118 (8), 1107-1114, 2018
242018
The RepID–CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation
SM Jang, JF Nathans, H Fu, CE Redon, LM Jenkins, BL Thakur, ...
Nature Communications 11 (1), 24, 2020
222020
Uncovering potential therapeutic targets in colorectal cancer by deciphering mutational status and expression of druggable oncogenes
O Menyhart, T Kakisaka, LS Pongor, H Uetake, A Goel, B Győrffy
Cancers 11 (7), 983, 2019
222019
The system can't perform the operation now. Try again later.
Articles 1–20